LIPOCINE INC.: cash and cash equivalents
Cash and cash equivalents for LIPOCINE INC. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All LIPOCINE INC. financial histories
What this measure means
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
Exact concept: us-gaap:CashAndCashEquivalentsAtCarryingValue. Each value is a balance at the reporting date, not a flow earned over a year. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2011-12-31 to 2025-12-31. The SEC response was captured on 2026-09-20.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| At date | 2025-12-31 | 5,205,842 | USD | 2026-03-10 | 10-K · 0001493152-26-009411 |
| At date | 2024-12-31 | 6,205,926 | USD | 2026-03-10 | 10-K · 0001493152-26-009411 |
| At date | 2023-12-31 | 4,771,758 | USD | 2025-03-13 | 10-K · 0001493152-25-010146 |
| At date | 2022-12-31 | 3,148,496 | USD | 2024-03-07 | 10-K · 0001493152-24-009127 |
| At date | 2021-12-31 | 2,950,552 | USD | 2023-03-10 | 10-K · 0001493152-23-007178 |
| At date | 2020-12-31 | 19,217,382 | USD | 2022-03-09 | 10-K · 0001493152-22-006353 |
| At date | 2019-12-31 | 9,728,523 | USD | 2021-03-11 | 10-K · 0001104659-21-034761 |
| At date | 2018-12-31 | 8,077,539 | USD | 2020-03-13 | 10-K · 0001104659-20-032764 |
| At date | 2017-12-31 | 3,210,749 | USD | 2019-03-06 | 10-K · 0001144204-19-012434 |
| At date | 2016-12-31 | 5,560,716 | USD | 2018-03-12 | 10-K · 0001144204-18-013981 |
| At date | 2015-12-31 | 20,007,659 | USD | 2018-03-12 | 10-K · 0001144204-18-013981 |
| At date | 2014-12-31 | 27,666,055 | USD | 2018-03-12 | 10-K · 0001144204-18-013981 |
| At date | 2013-12-31 | 45,263,698 | USD | 2017-03-06 | 10-K · 0001144204-17-012930 |
| At date | 2012-12-31 | 5,377,114 | USD | 2015-03-11 | 10-K · 0001144204-15-015256 |
| At date | 2011-12-31 | 8,567,823 | USD | 2014-03-31 | 10-K · 0001144204-14-019291 |
Related financial histories
- LIPOCINE INC.: total assets
- LIPOCINE INC.: total liabilities
- LIPOCINE INC.: stockholders equity
- LIPOCINE INC.: net income or loss
- LIPOCINE INC.: operating cash flow
- LIPOCINE INC.: capital expenditure payments
- LIPOCINE INC.: revenue
- LIPOCINE INC.: financing cash flow
- LIPOCINE INC.: investing cash flow
- LIPOCINE INC.: retained earnings or deficit
- LIPOCINE INC.: basic weighted-average shares
- LIPOCINE INC.: diluted weighted-average shares
- LIPOCINE INC.: basic earnings per share
- LIPOCINE INC.: diluted earnings per share
- LIPOCINE INC.: income tax expense or benefit
- LIPOCINE INC.: net property, plant and equipment
- LIPOCINE INC.: share-based compensation expense
- LIPOCINE INC.: operating income or loss
- LIPOCINE INC.: current assets
- LIPOCINE INC.: interest expense
- LIPOCINE INC.: current liabilities
- LIPOCINE INC.: current accounts payable
- LIPOCINE INC.: operating expenses
- LIPOCINE INC.: research and development expense
Inspect the source
- Entity
- LIPOCINE INC. / CIK 0001535955
- Captured
- 2026-09-20T09:16:59.475Z
- SEC response SHA-256
fc6b1f5b710fdd1e50873bb5567fd88fca6380fc2de8a24324b8b2dd733b35ce
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001535955.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))